RxDoctor Payments Data

Kennith Layton, MD

Diagnostic Radiology · Dallas, TXNPI 1194705301

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.7%), other and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Stryker at 56.0% of the total. Reporting peaked in 2023 at $33,875 and has fallen 95.5% since, to $1,522 in 2025. Among diagnostic radiology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,750in general payments, 2019–2025

Across 142 payments — averaging $385.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$31K
  • Medtronic$20K
  • Bard Peripheral Vascular, Inc.$1K
  • Imperative Care, Inc$837
  • Inari Medical, Inc.$484
  • Johnson & Johnson$433
  • plus $984 from 13 others
$201,699in research payments, 2019–2025

Across 56 payments — averaging $3601.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Imperative Care, Inc$125K
  • Microvention, Inc.$51K
  • Penumbra, Inc.$26K

What the payments were for

  • Consulting fees$29,94755%
  • Travel & lodging$1,3943%
  • Food & beverage$4,0487%
  • Other$19,36135%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,750 in reported general payments places this provider in the 95th percentile of 2,506 diagnostic radiology providers in Texas.

See all diagnostic radiology providers in Texas

Medicare billing

Part B allowed, 2024
$78,891
Medicare patients
504
Services billed
840

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate16$157

Paid to pharmacies, not to this prescriber.

Other diagnostic radiology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →